5.75
+0.02(+0.35%)
Currency In USD
| Previous Close | 5.73 |
| Open | 5.74 |
| Day High | 5.75 |
| Day Low | 5.73 |
| 52-Week High | 12.96 |
| 52-Week Low | 3.73 |
| Volume | 48,807 |
| Average Volume | 54,556 |
| Market Cap | 34.66M |
| PE | -0.27 |
| EPS | -21.4 |
| Moving Average 50 Days | 5.6 |
| Moving Average 200 Days | 5.84 |
| Change | 0.02 |
If you invested $1000 in Science 37 Holdings, Inc. (SNCE) since IPO date, it would be worth $28.08 as of December 26, 2024 at a share price of $5.75. Whereas If you bought $1000 worth of Science 37 Holdings, Inc. (SNCE) shares 3 years ago, it would be worth $21.57 as of December 26, 2024 at a share price of $5.75.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Data not available
Science 37 Nearly Doubles U.S. Enrollment for GSK Phase 3 Rare Disease Trial
GlobeNewswire Inc.
Nov 21, 2024 1:00 PM GMT
MORRISVILLE, N.C., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, was a key enrolling site for the primary completion of a Phase 3 rare disease trial sponsored by global biopharmaceutical comp
Science 37 Earns Frost & Sullivan’s 2024 Global Company of the Year Award for Decentralized Clinical Trials
GlobeNewswire Inc.
Sep 16, 2024 12:00 PM GMT
Top Honor Recognizes Science 37’s Visionary Innovation, Market-Leading Performance, and Unmatched Customer Care in the Decentralized Clinical Trials IndustryMORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Today, Science 37, a leader in enhanc